Senzime AB (SEZI) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.081x

Based on the latest financial reports, Senzime AB (SEZI) has a cash flow conversion efficiency ratio of -0.081x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-23.03 Million ≈ $-2.48 Million USD) by net assets (Skr283.50 Million ≈ $30.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SEZI days of operational coverage to measure how many days the company can operate on defensive assets alone.

Senzime AB - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Senzime AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Senzime AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Senzime AB ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Vakrangee Limited
NSE:VAKRANGEE
0.093x
SRV Group plc
HE:SRV1V
0.076x
e-LITECOM CO. Ltd
KQ:041520
-0.006x
AGROB Immobilien AG
F:AGR
N/A
Cintac
SN:CINTAC
0.119x
CHAPEL DOWN GRP PLC LS-05
F:1U6
N/A
Shanghai Shibei Hi-Tech Co Ltd B
SHG:900902
-0.011x
Siebert Financial Corp
NASDAQ:SIEB
-0.296x

Annual Cash Flow Conversion Efficiency for Senzime AB (2006–2025)

The table below shows the annual cash flow conversion efficiency of Senzime AB from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see SEZI company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr304.46 Million
≈ $32.76 Million
Skr-109.10 Million
≈ $-11.74 Million
-0.358x -16.98%
2024-12-31 Skr345.86 Million
≈ $37.22 Million
Skr-105.94 Million
≈ $-11.40 Million
-0.306x -0.97%
2023-12-31 Skr375.48 Million
≈ $40.41 Million
Skr-113.91 Million
≈ $-12.26 Million
-0.303x +41.91%
2022-12-31 Skr261.90 Million
≈ $28.18 Million
Skr-136.78 Million
≈ $-14.72 Million
-0.522x +3.31%
2021-12-31 Skr150.58 Million
≈ $16.20 Million
Skr-81.33 Million
≈ $-8.75 Million
-0.540x -225.94%
2020-12-31 Skr231.35 Million
≈ $24.90 Million
Skr-38.34 Million
≈ $-4.13 Million
-0.166x +0.04%
2019-12-31 Skr163.69 Million
≈ $17.62 Million
Skr-27.14 Million
≈ $-2.92 Million
-0.166x -56.49%
2018-12-31 Skr167.41 Million
≈ $18.02 Million
Skr-17.73 Million
≈ $-1.91 Million
-0.106x -21.04%
2017-12-31 Skr140.46 Million
≈ $15.12 Million
Skr-12.29 Million
≈ $-1.32 Million
-0.088x -15.36%
2016-12-31 Skr131.87 Million
≈ $14.19 Million
Skr-10.00 Million
≈ $-1.08 Million
-0.076x +45.81%
2015-12-31 Skr45.81 Million
≈ $4.93 Million
Skr-6.41 Million
≈ $-690.18K
-0.140x -60.40%
2014-12-31 Skr44.08 Million
≈ $4.74 Million
Skr-3.85 Million
≈ $-414.05K
-0.087x +39.78%
2013-12-31 Skr37.46 Million
≈ $4.03 Million
Skr-5.43 Million
≈ $-584.31K
-0.145x +23.55%
2012-12-31 Skr31.99 Million
≈ $3.44 Million
Skr-6.06 Million
≈ $-652.57K
-0.190x -170.80%
2011-12-31 Skr27.87 Million
≈ $3.00 Million
Skr-1.95 Million
≈ $-209.94K
-0.070x +27.67%
2010-12-31 Skr21.90 Million
≈ $2.36 Million
Skr-2.12 Million
≈ $-228.10K
-0.097x -0.30%
2009-12-31 Skr16.61 Million
≈ $1.79 Million
Skr-1.60 Million
≈ $-172.54K
-0.096x -664.63%
2006-12-31 Skr7.55 Million
≈ $812.29K
Skr129.00K
≈ $13.88K
0.017x --

About Senzime AB

ST:SEZI Sweden Medical Devices
Market Cap
$74.61 Million
Skr693.32 Million SEK
Market Cap Rank
#20433 Global
#367 in Sweden
Share Price
Skr4.41
Change (1 day)
-1.45%
52-Week Range
Skr4.10 - Skr7.27
All Time High
Skr26.50
About

Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The company offers TetraGraph, quantitative train of-four (TOF) monitoring refined by real-world patient data; and ExSpiron, a non-invasive monitoring system that uses bioelectrical impeda… Read more